Skip to main content
Journal cover image

Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery.

Publication ,  Journal Article
Spyropoulos, AC; Al-Badri, A; Sherwood, MW; Douketis, JD
Published in: J Thromb Haemost
May 2016

The periprocedural management of patients receiving chronic therapy with oral anticoagulants (OACs), including vitamin K antagonists (VKAs) such as warfarin and direct OACs (DOACs), is a common clinical problem. The optimal perioperative management of patients receiving chronic OAC therapy is anchored on four key principles: (i) risk stratification of patient-related and procedure-related risks of thrombosis and bleeding; (ii) the clinical consequences of a thrombotic or bleeding event; (iii) discontinuation and reinitiation of OAC therapy on the basis of the pharmacokinetic properties of each agent; and (iv) whether aggressive management such as the use of periprocedural heparin bridging has advantages for the prevention of postoperative thromboembolism at the cost of a possible increase in bleeding risk. Recent data from randomized trials in patients receiving VKAs undergoing pacemaker/defibrillator implantation or using heparin bridging therapy for elective procedures or surgeries can now inform best practice. There are also emerging data on periprocedural outcomes in the DOAC trials for patients with non-valvular atrial fibrillation. This review summarizes the evidence for the periprocedural management of patients receiving chronic OAC therapy, focusing on recent randomized trials and large outcome studies, to address three key clinical scenarios: (i) can OAC therapy be safely continued for minor procedures or surgeries; (ii) if therapy with VKAs (especially warfarin) needs to be temporarily interrupted for an elective procedure/surgery, is heparin bridging necessary; and (iii) what is the optimal periprocedural management of the DOACs? In answering these questions, we aim to provide updated clinical guidance for the periprocedural management of patients receiving VKA or DOAC therapy, including the use of heparin bridging.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Thromb Haemost

DOI

EISSN

1538-7836

Publication Date

May 2016

Volume

14

Issue

5

Start / End Page

875 / 885

Location

England

Related Subject Headings

  • Warfarin
  • Vitamin K
  • United States
  • Thrombosis
  • Thromboembolism
  • Societies, Medical
  • Randomized Controlled Trials as Topic
  • Prothrombin
  • Phenprocoumon
  • Perioperative Care
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Spyropoulos, A. C., Al-Badri, A., Sherwood, M. W., & Douketis, J. D. (2016). Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery. J Thromb Haemost, 14(5), 875–885. https://doi.org/10.1111/jth.13305
Spyropoulos, A. C., A. Al-Badri, M. W. Sherwood, and J. D. Douketis. “Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery.J Thromb Haemost 14, no. 5 (May 2016): 875–85. https://doi.org/10.1111/jth.13305.
Spyropoulos AC, Al-Badri A, Sherwood MW, Douketis JD. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery. J Thromb Haemost. 2016 May;14(5):875–85.
Spyropoulos, A. C., et al. “Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery.J Thromb Haemost, vol. 14, no. 5, May 2016, pp. 875–85. Pubmed, doi:10.1111/jth.13305.
Spyropoulos AC, Al-Badri A, Sherwood MW, Douketis JD. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery. J Thromb Haemost. 2016 May;14(5):875–885.
Journal cover image

Published In

J Thromb Haemost

DOI

EISSN

1538-7836

Publication Date

May 2016

Volume

14

Issue

5

Start / End Page

875 / 885

Location

England

Related Subject Headings

  • Warfarin
  • Vitamin K
  • United States
  • Thrombosis
  • Thromboembolism
  • Societies, Medical
  • Randomized Controlled Trials as Topic
  • Prothrombin
  • Phenprocoumon
  • Perioperative Care